Ingredion releases transcript of Q2 2026 earnings call
INGR•Second-quarter results
2Q net sales rose 1% to $1.85 billion; adjusted operating income fell 5% to $258 million on Argo disruption and Mexico pressures.
Guidance and Tate & Lyle deal
Guidance was reaffirmed: 2026 adjusted EPS of $10.3-10.9.
The Tate & Lyle deal targets $2.7 billion in revenue and $130 million in synergies by 2030.
Segment trends and operating updates
Texture and Healthful Solutions net sales rose 5% on 7% volume growth; tapioca root costs rose over 40% YTD, with pricing lagging by 1-1.5 quarters.
Argo exited June at normal production rates; management expects historical margins toward year-end as inventory costs clear.
Q2 earnings call participants and key topics
Ingredion’s 2Q 2026 earnings call drew CEO James Zallie, Interim CFO Jason Payant, and IR VP Noah Weiss; analysts joined from Oppenheimer, Benchmark, Barclays, Stephens, BMO, UBS, and Heather Jones Research.
